Skip to Main Content

Author Details

Yusuke Goto
Chiba University Graduate School of Medicine
2011
71
32
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36754848MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3.FEBS Lett2023
37592434Off-clamp robot-assisted partial nephrectomy for renal hilar tumors.Int J Urol2023
37608517Editorial Comment to Evaluation of sexual function after robot-assisted radical prostatectomy: A farewell to IIEF questionnaire.Int J Urol2023
37608457Editorial Comment to Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG-treated disease.Int J Urol2023
37500129Investigation on the Usefulness of Photodynamic Diagnosis-assisted Targeted Bladder Biopsy: Japanese Real-world Study.Anticancer Res2023
37188580Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomas.Surgery2023
36980524Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data.Cancers (Basel)2023
37144081A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy.IJU Case Rep2023
37431967Evaluating first-line immuno-oncology-based treatments for metastatic renal cell carcinoma in real world clinical practice using pre-treatment G8 scores.Int J Urol2023
37130793Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era.Int J Urol2023
36852924Editorial Comment to Stereotactic body radiation therapy for kidney cancer. Where do we stand?Int J Urol2023
36482811Editorial comment to real-world outcomes of pembrolizumab for platinum refractory advanced urothelial carcinoma: Efficacy, safety, and evidence for trial-unfit patients.Int J Urol2023
36124637Editorial Comment to miRNAs in prostate cancer: Intercellular and extracellular communications.Int J Urol2022
35795120Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis.IJU Case Rep2022
36001768Editorial Comment to Trends in primary treatment for localized prostate cancer according to the availability of treatment modalities and the impact of introducing robotic surgery.Int J Urol2022
36232922Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive <i>miR-139-3p</i>.Int J Mol Sci2022
34201353Identification of Tumor Suppressive Genes Regulated by <i>miR-31-5p</i> and <i>miR-31-3p</i> in Head and Neck Squamous Cell Carcinoma.Int J Mol Sci2021
33888713Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.Nat Commun2021
34725466EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.Commun Biol2021
34591642A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.Science2021
32205868Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis.Oncogene2020
33322675Regulation of Oncogenic Targets by the Tumor-Suppressive <i>miR-139</i> Duplex (<i>miR-139-5p</i> and <i>miR-139-3p</i>) in Renal Cell Carcinoma.Biomedicines2020
32623445RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.J Hum Genet2020
32727882Tipifarnib as a Precision Therapy for <i>HRAS</i>-Mutant Head and Neck Squamous Cell Carcinomas.Mol Cancer Ther2020
30910656Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.Ann Thorac Surg2019
31804466Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4.Nat Commun2019
31292160Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.Cancer Res2019
29531336Molecular pathogenesis of interstitial cystitis based on microRNA expression signature: miR-320 family-regulated molecular pathways and targets.J Hum Genet2018
27278788Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.J Hum Genet2017
30333441[KOUJIN POWDER (RED GINSENG POWDER) WITH NINJIN-YOUEITO FOR FATIGUE DUE TO TARGETED THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A RETROSPECTIVE COHORT STUDY].Nihon Hinyokika Gakkai Zasshi2017
28534948Dual strands of pre-miR⿿150 (miR⿿150⿿5p and miR⿿150⿿3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.Int J Oncol2017
28641312Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.Br J Cancer2017
27734836Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.J Hum Genet2017
27357429Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.J Hum Genet2017
27278789The roles of microRNAs in the progression of castration-resistant prostate cancer.J Hum Genet2017
26793880[The mechanisms of prostate cancer progression through androgen receptor].Nihon Rinsho2016
26490187Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.J Hum Genet2016
26509963Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.Cancer Sci2016
26450768Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men.Int J Urol2016
26676674Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.Int J Oncol2016
27765924Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.Oncotarget2016
27633630Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.Int J Oncol2016
27344709[Mutation of androgen receptor].Nihon Rinsho2016
27344703[Molecular biology and genetics of prostate cancer].Nihon Rinsho2016
27487138The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma.Oncotarget2016
27212625Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.Int J Oncol2016
27072587Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.Oncotarget2016
27070713Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.Br J Cancer2016
26983694Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.Int J Oncol2016
27012365Real-Time GFP Intravital Imaging of the Differences in Cellular and Angiogenic Behavior of Subcutaneous and Orthotopic Nude-Mouse Models of Human PC-3 Prostate Cancer.J Cell Biochem2016
  • 1 - 50 of 71

Recommended Authors

Christianne Hoey
Evaluative Clinical Sciences, Sunnybrook Research Institute
Career Start Year 2017
Number of shared co-authors 0
Jiayu Liang
institute of urology
Career Start Year 2016
Number of shared co-authors 0
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year 2015
Number of shared co-authors 0
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 0
Yasheng Zhu
Changhai Hospital, Naval Military Medical University
Career Start Year 2014
Number of shared co-authors 0
Yuliang Wang
The Chinese University of Hong Kong
Career Start Year 2014
Number of shared co-authors 0
Fubo Wang
Center for Genomic and Personalized Medicine, Guangxi Medical University
Career Start Year 2011
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 0
Shancheng Ren
Shanghai Changzheng Hospital
Career Start Year 2007
Number of shared co-authors 0
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 0
Song Wu
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Career Start Year 2006
Number of shared co-authors 0
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 0
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 0
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 0
Lin Qi
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 1
Xiaojie Bian
Fudan University Shanghai Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Seok-Soo Byun
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Yongwei Yu
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 1
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 0
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 0
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 0
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 1
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 0

Collaborators

Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 8
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Co-authored papers 7
Mara Gilardi
Institute of Medical Genetics and Pathology.
Co-authored papers 5
Alfredo A Molinolo
University of California
Co-authored papers 3
Ezra E W Cohen
university of california san diego Health System
Co-authored papers 2
Michael M Allevato
University of Michigan Medical School.
Co-authored papers 2
Nadia Arang
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Jennifer R Grandis
University of California san francisco
Co-authored papers 2
Neil E Bhola
Zai Lab (US) LLC
Co-authored papers 1
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 1
Kari A Herrington
Center for Advanced Light Microscopy, University of California san francisco
Co-authored papers 1
Fan Zheng
University of California San Diego
Co-authored papers 1
Xingyu Wu
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Nathan K VanLandingham
Co-authored papers 1
Nan Jin
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Jisoo Park
University of California San Diego san francisco
Co-authored papers 1
Yan Zeng
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers 1
Jason F Kreisberg
University of California San Diego
Co-authored papers 1
Daniel E Johnson
University of California San Francisco
Co-authored papers 1
Robert M Hoffman
Co-authored papers 1
Michael Bouvet
Co-authored papers 1
Kyumin Kim
Inje Institute of Pharmaceutical Sciences and Research, Inje University
Co-authored papers 1
Joseph A Califano
University of California
Co-authored papers 1
Rachel A O'Keefe
University of California San Francisco
Co-authored papers 1
Dana J Ramms
University of California San Diego
Co-authored papers 1
Kirsten Obernier (CM4AI)
University of California San Francisco
Co-authored papers 1
Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
Co-authored papers 1
Margaret Soucheray
J. David Gladstone Institutes
Co-authored papers 1
John Von Dollen
University of California San Francisco
Co-authored papers 1
Release 1.2